Rare Disease Patients in Uttar Pradesh Forced to Abandon Treatment Amid Funding Crisis
source: pixabay.com

Rare Disease Patients in Uttar Pradesh Forced to Abandon Treatment Amid Funding Crisis

According to a publication from ET Healthworld, some 21 rare disease patients in India's northern state of Uttar Pradesh are still awaiting governmental financial assistance to which they are legally…

Continue Reading Rare Disease Patients in Uttar Pradesh Forced to Abandon Treatment Amid Funding Crisis

FDA Clears Phase 2 Trial for Possible Idiopathic Pulmonary Fibrosis Drug

According to a story from BioPortfolio, the biopharmaceutical company Genkyotex has recently announced that the US Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application.…

Continue Reading FDA Clears Phase 2 Trial for Possible Idiopathic Pulmonary Fibrosis Drug

Since 1982, Over 16 Million People Have Been Cured of Hansen’s Disease Worldwide, But a Major Struggle Remains in Brazil

  According to a report recently published in the Inter Press Service, since the advent of multidrug therapy in 1982, over sixteen million people have been cured of Hansen’s disease,…

Continue Reading Since 1982, Over 16 Million People Have Been Cured of Hansen’s Disease Worldwide, But a Major Struggle Remains in Brazil
Experimental Netherton Syndrome Treatment Receives Rare Pediatric Disease Designation from FDA
source: pixabay.com

Experimental Netherton Syndrome Treatment Receives Rare Pediatric Disease Designation from FDA

According to a press release from LifeMax Laboratories, Inc., the Food and Drug Administration (FDA) has granted the Company's experimental Netherton syndrome drug LM-030 (licensed from Novartis) Rare Pediatric Disease…

Continue Reading Experimental Netherton Syndrome Treatment Receives Rare Pediatric Disease Designation from FDA
Possible Treatment for Homozygous Familial Hypercholesterolemia Earns Orphan Drug Designation
katicaj / Pixabay

Possible Treatment for Homozygous Familial Hypercholesterolemia Earns Orphan Drug Designation

According to a story from bloomberg.com, the drug development company Arrowhead Pharmaceuticals, Inc. recently announced that its experimental product candidate AR0-ANG3 has earned Orphan Drug designation from the US Food…

Continue Reading Possible Treatment for Homozygous Familial Hypercholesterolemia Earns Orphan Drug Designation
Antibodies: The Key to Fighting Sickle Cell Anemia? Approval Could be Just Months Away
kalhh / Pixabay

Antibodies: The Key to Fighting Sickle Cell Anemia? Approval Could be Just Months Away

According to a story from PMLive, the US Food and Drug Administration (FDA) has recently begun the priority review process for a new potential therapy from pharmaceutical behemoth Novartis. This…

Continue Reading Antibodies: The Key to Fighting Sickle Cell Anemia? Approval Could be Just Months Away

Patients with Amyotrophic Lateral Sclerosis Can Now Change the TV Channel with Just Their Eyes

For rare disease patients who face physical disabilities, even seemingly simple tasks can pose extreme difficulties. For instance, changing the channel on the television. Comcast Corp. previously created a voice…

Continue Reading Patients with Amyotrophic Lateral Sclerosis Can Now Change the TV Channel with Just Their Eyes

Study Determines More Research is Needed Regarding the Effect of Body Weight on Juvenile Idiopathic Arthritis

The Study Juvenile idiopathic arthritis (JIA) is a rare disease that causes inflammation in the joints. It is of unknown origin and has no cure. Previous investigations in studies with…

Continue Reading Study Determines More Research is Needed Regarding the Effect of Body Weight on Juvenile Idiopathic Arthritis

The Rare Barometer Program Helps Politicians Stay Informed on Issues Important to Rare Disease Patients

Eurordis-Rare Diseases Europe Eurordis-Rare Diseases Europe is an alliance of patient organizations which works to give rare patients a voice. It also strives to spread awareness of rare diseases to…

Continue Reading The Rare Barometer Program Helps Politicians Stay Informed on Issues Important to Rare Disease Patients

A Plasma Shortage is Affecting Common Variable Immune Deficiency Patient’s Access to Treatment

Heather White Heather White is a 41-year-old woman who was diagnosed with common variable immune deficiency (CVID) back in 2004 after fighting frequent bouts of pneumonia. Doctors believe that she…

Continue Reading A Plasma Shortage is Affecting Common Variable Immune Deficiency Patient’s Access to Treatment

Gaucher Disease Patient and Activist Successfully Improves the Care for Other Rare Disease Patients in Her Country

This is the story of a brave journalist who was determined to improve care for rare disease patients in her country, North Macedonia. North Macedonia is a developing country located…

Continue Reading Gaucher Disease Patient and Activist Successfully Improves the Care for Other Rare Disease Patients in Her Country

University of Michigan Professor Creates Website to Provide Scleroderma Patients Resources and Support

Dinesh Khanna, a professor at the University of Michigan has worked heavily with the rare disease scleroderma. Michigan has its own Scleroderma Program, of which Khanna is the director. Through…

Continue Reading University of Michigan Professor Creates Website to Provide Scleroderma Patients Resources and Support
Phase 3 Trial of Experimental Progressive Familial Intrahepatic Cholestasis Drug for Pediatric Patients Begins
DarkoStojanovic / Pixabay

Phase 3 Trial of Experimental Progressive Familial Intrahepatic Cholestasis Drug for Pediatric Patients Begins

According to a story from drugs.com, the biopharmaceutical company Mirum Pharmaceuticals recently announced that they have begun dosing the first patient in a phase 3 clinical trial. This clinical trial…

Continue Reading Phase 3 Trial of Experimental Progressive Familial Intrahepatic Cholestasis Drug for Pediatric Patients Begins
FDA Approves Soliris for Treatment of Neuromyelitis Optica Spectrum Disorder
source: pixabay.com

FDA Approves Soliris for Treatment of Neuromyelitis Optica Spectrum Disorder

According to a publication at Markets Insider, the Food and Drug Administration (FDA) recently approved Soliris (eculizumab) as a treatment for neuromyelitis optica spectrum disorder. The approval marks the first…

Continue Reading FDA Approves Soliris for Treatment of Neuromyelitis Optica Spectrum Disorder

Recent Study Indicates Lyso-Gb1 is an Extremely Effective Biomarker for Monitoring Children with Gaucher Disease

Gaucher disease (GD) is a rare lysosomal storage disorder. It is caused by a deficiency in the glucocerebrosidase enzyme. In June, a new study was published in the International Journal of…

Continue Reading Recent Study Indicates Lyso-Gb1 is an Extremely Effective Biomarker for Monitoring Children with Gaucher Disease

Spina Bifida Patient Publishes First Book “Crotch Height Perspective” Discussing How She Embraces Life in a Wheelchair

Growing up "Normal" Growing up, Steph Derham always thought she was normal. She says she has her parents to thank for that. Steph is incredibly grateful that her mom and…

Continue Reading Spina Bifida Patient Publishes First Book “Crotch Height Perspective” Discussing How She Embraces Life in a Wheelchair

Singapore Launches the Rare Disease Fund to Help Patients Cope with Exorbitant Drug Costs

Rare Disease Fund Many families affected by rare diseases cannot afford the necessary treatments. Due to the small population of people these diseases affect, exorbitant price tags are often placed…

Continue Reading Singapore Launches the Rare Disease Fund to Help Patients Cope with Exorbitant Drug Costs